1. Repeated-dose liver micronucleus assay: an investigation with 2-nitropropane, a hepatocarcinogen.
- Author
-
Kawakami S, Araki T, Nakajima M, Kusuoka O, Uchida K, Sato N, Tanabe Y, Takahashi K, Wako Y, Kawasako K, and Tsurui K
- Subjects
- Administration, Oral, Animals, Body Weight drug effects, Bone Marrow drug effects, Chromosome Aberrations drug effects, Cooperative Behavior, Dose-Response Relationship, Drug, Drug Administration Schedule, Hepatocytes pathology, Humans, Japan, Liver pathology, Male, Organ Specificity, Propane toxicity, Rats, Rats, Sprague-Dawley, Reticulocytes drug effects, Societies, Pharmaceutical, Carcinogens toxicity, Hepatocytes drug effects, Liver drug effects, Micronucleus Tests, Nitroparaffins toxicity, Propane analogs & derivatives
- Abstract
The utility of the repeated-dose liver micronucleus (RDLMN) assay in the detection of a genotoxic hepatocarcinogen was evaluated. In this paper, a rat hepatocarcinogen, 2-nitropropane (2-NP), was administered orally to young adult rats for 14 and 28 days without a partial hepatectomy or a mitogen, and the micronucleus induction in liver was examined using a simple method to isolate hepatocytes. In addition, a bone marrow micronucleus assay was conducted concomitantly. The frequency of micronucleated hepatocytes induced by 2-NP increased significantly in both the 14- and 28-day repeated-dose studies, while the bone marrow micronucleus assays were negative in each study. These results indicate that the RDLMN assay is useful for detecting a genotoxic hepatocarcinogen that is negative in bone marrow micronucleus assays and is a suitable in vivo genotoxicity test method for integration into a repeated-dose general toxicity study., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF